Mylan CEO set to defend EpiPen prices amid public outcry

Mylan CEO set to defend EpiPen prices amid public outcry


In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. Mylan CEO Heather Bresch is defending the cost for life-saving EpiPens and is offering no suggestion that there are plans to lower prices.



from Biotech News